Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Q&A: 'Convenience is a major selling point' for new colorectal cancer blood test
The new blood test screening option for colorectal cancer is innovative and could improve screening uptake, but it also has some drawbacks, according to an expert.
VIDEO: Dietary modification ‘puts power in our hands’ to reduce risk for early-onset CRC
In Healio video exclusive, Suneel Kamath, MD, reports a diet, especially one high in red and processed meats may be linked to an increased risk for early-onset colorectal cancer.
Log in or Sign up for Free to view tailored content for your specialty!
NSAIDs, Part 3: The rise, fall and rise again of COX-2 inhibition
In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?
Rurality, poverty linked to shorter survival in early-onset colorectal cancer
Analyses of people with early-onset colorectal cancer showed those who lived in rural areas had greater 5-year disease-related mortality risk than those who lived in nonrural areas, according to results of a retrospective study.
AGA: ‘Keep both patient and fetus safe’ when managing GI, liver diseases in pregnancy
Multidisciplinary care is key when managing patients with pregnancy-related gastrointestinal and liver diseases, with a “paramount goal” of keeping both the patient and the fetus safe, according to an AGA clinical practice update.
AI-based GI Genius boosts adenoma, sessile serrated lesion detection vs. colonoscopy alone
An AI-assisted endoscopy module increased adenoma detection, including sessile serrated lesions, during colonoscopy and is recommended in routine practice to reduce incidence of post-procedure colorectal cancer, according to researchers.
Metastasis-directed radiation therapy may be ‘paradigm shift’ in advanced pancreatic cancer
The addition of comprehensive metastasis-directed radiation therapy to chemotherapy improved outcomes for patients with oligometastatic pancreatic ductal adenocarcinoma, according to results of a randomized phase 2 basket trial.
Prognostic tool may identify those with BE at higher risk for developing esophageal cancer
The biomarker-based Esopredict determined that patients with Barrett’s esophagus who were stratified as higher risk were 6.4-times more likely to progress to high-grade dysplasia or esophageal adenocarcinoma within 5 years, research showed.
New ACG, ASGE quality indicators for colonoscopy include 3 key updates
Revised quality indicators released by the ACG and ASGE highlight the importance of adenoma and sessile serrated lesion detection rates as well as adequate bowel preparation for improving the technical performance of colonoscopy.
Neoadjuvant immunotherapy may broaden surgery eligibility for hepatocellular carcinoma
Neoadjuvant immunotherapy may allow more people with hepatocellular carcinoma to undergo surgical resection, according to retrospective study results.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read